Drug Trial Radar · NCT06602258
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
Last checked: Nov 19, 2026Latest source record: Feb 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
105
Actual
Start
Sep 30, 2024
Primary completion
Dec 3, 2026
Study completion Aug 18, 2027
Sponsor
- Lead sponsor
- Eisai Inc.Eisai
- Sponsor type
- Industry
- First posted
- Sep 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to determine the dose response of E2814, when concurrently administered with lecanemab, on the change from baseline at 6 months in cerebrospinal fluid (CSF) microtubule-binding region (MTBR)-tau-243 in participants with early Alzheimer's disease (AD).
Conditions
- Alzheimer's Disease
Interventions
E2814Drug
E2814 IV infusion.
LecanemabDrug
Lecanemab SC injection.
PlaceboDrug
Placebo IV infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in CSF MTBR-tau-243 at 6 MonthsTime frame: Baseline at 6 months
Locations
26 sites in 2 countries. Site status is shown where the registry gives one.
Banner Sun Health Research
Phoenix, Arizona
Yale University School of Medicine
New Haven, Connecticut
Bradenton Research Center
Bradenton, Florida
K2 Medical Research
Clermont, Florida
Advanced Clinical Research Network
Miami, Florida
Renstar Medical Research
Ocala, Florida
Progressive Medical Research
Port Orange, Florida
Alzheimer's Research and Treatment Center-Stuart
Stuart, Florida
Axiom Brain Health
Tampa, Florida
Charter Research
The Villages, Florida
Alzheimer's Research and Treatment Center
Wellington, Florida
Columbus Memory Center, PC
Columbus, Georgia
Hattiesburg Clinic
Hattiesburg, Mississippi
Washington University School of Medicine
St Louis, Missouri
Abington Neurological Associates LTD
Abington, Pennsylvania
Neurology Clinic, P.C.
Cordova, Tennessee
Kerwin Memory Center
Dallas, Texas
National Clinical Research-Richmond, Inc
Richmond, Virginia
Osaka Metropolitan University Hospital
Osaka, Japan
Yamagata Tokushukai Hospital
Yamagata, Japan
National Center for Geriatrics and Gerontology
Ōbu, Aichi-ken, Japan
National Hospital Organization Hiroshima-Nishi Medical Center
Ōtake, Hiroshima, Japan
Keimei Memorial Hospital
Honjō, Miyazaki, Japan
Rijikai Medical Corporation Katayama Medical Clinic
Kurashiki, Okayama-ken, Japan
Tokyo Medical University Hospital
Shinjuku, Tokyo, Japan
Keio University Hospital
Shinjuku, Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.